Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Strides Arcolab arm receives US FDA nod for Chemotherapy Drug

Posted On: 2012-08-07 23:16:29

Strides Arcolab's subsidiary Onco Therapies Limited has received final ANDA approval for Oxaliplatin Injection 50mg/10mL and 100mg/20mL.

The company had receive tentative approval from USFDA in November 2011 based on a Para III filing. This approval was later converted to a Para IV filing based on which USFDA has now granted final approval.

According to IMS data, the US market for generic Oxaliplatin is approximately $1.5 billion.

Oxaliplatin is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.

Oxaliplatin is a chemotherapy drug used to treat advanced cancer of the colon and rectum. It is used in combination with other medications to slow or stop cancer cell growth.

The Strides Arcolab Ltd. stock was trading at Rs.754.45, up by Rs.30.05 or 4.15%. The stock hit an intraday high of Rs.760.05 and low of Rs.729.

The total traded quantity was 0.49 lakhs compared to 2 week average of 0.40 lakhs.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Tata Power Delhi Distribution wins Platts Global Energy Awards, 2014 for CSR Initiatives
Logistics companies to be biggest beneficiaries of GST: Shashi Kiran Shetty, ALLCARGO LOGISTICS
Bajaj Auto secures repeat order from Sri Lanka for Discover-125M motorcycles
TM Forum and Subex survey reveals the magnitude of Capex challenge globally
Transformers and Rectifiers enters into Technology License Agreement with Fuji
NIIT Technologies helps Air Tahiti Nui to launch 5 new regional websites
Unno Industries Ltd Board approves acquisition of NPASource.com
Avanti Feeds Ltd Shifts Registered Office to Visakhapatnam
MM Rubber Company Ltd to consider quarterly results on Jan 30, 2015
Amines & Plasticizers Ltd Board to consider Stock Split
HOV Services Ltd appoints Company Secretary
Bajaj Auto Ltd to announce Q3 results on Jan 15, 2015
Rajasthan Government takes back lime stone mine from UltraTech Cement Ltd
Veljan Denison Ltd accepts resignation of MD
EXIM Bank withdraws Nomination of Director from Innoventive Industries Ltd
Shantanu Sheorey Aquakult Ltd to acquire Four Lions Films Pvt. Ltd.
Haryana Financial Corporation Ltd gets new Managing Director
Steel Exchange India Ltd Fixes Book Closure for 2013-14 AGM
ICRA upgrades credit ratings of SRS Ltd
Bajaj Holdings & Investment Ltd to announce Q3 results on Jan 15, 2015
Disa India Ltd announces change in ownership
HCL Infosystems Ltd clarifies on pact with Mongo DB
Jet Infraventure Ltd appoints additional director
Patel Engineering Ltd announces demise of Director
State Bank of Travancore Board approves draft letter of offer for rights issue
Bajaj Finserv Ltd to announce Q3 results on Jan 14, 2015
Indian Oil Corporation Ltd clarifies on capacity expansion
JMD Telefilms Industries Ltd Fixes Record Date for Bonus Issue
G Veera Bhadram ceased to be whole-time Director of Sabero Organics Gujarat Ltd
City Union Bank opens new branches at Visakhapatnam, Vizianagaram
Pincon Spirit Ltd approves launch of whiskey
City Union Bank Ltd to consider delisting from Madras Stock Exchange
Thirthankar Infra Ltd changes name as PVV Infra Ltd
Networth Stock Broking Ltd Fixes Book Closure for 21st AGM
Bajaj Finance Ltd to announce Q3 results on Jan 14, 2015
Kesar Terminals & Infrastructure Ltd's Director passes away
Advani Hotels & Resorts announces demise of Director
Jindal Photo to consider scheme or arrangement with Jindal Poly Films
Lyka Labs Ltd Fixes Book Closure for 35th AGM
Cambridge Technology Enterprises Ltd revises Book Closure for AGM
Kesar Enterprises Ltd announces demise of Independent Director
Jindal Poly Films to consider scheme or arrangement with Jindal Photo
Panacea Biotec enters into pact with Rising Pharmaceuticals Inc.
Dr. Reddy's Laboratories completes acquisition of Habitrol® Brand from Novartis
Rajasthan Petro Synthetics Ltd appoints Woman Director
Rollatainers Ltd to open 550 new Barista Outlets in 5 years
Visa Steel Ltd approves merger
Punj Lloyd Ltd receives FIPB Approval for manufacture of defence items
Hester Biosciences Ltd calls for Board Meeting on Dec 24, 2014
C Mahendra Exports Ltd to change name as C Mahendra Ltd


  
Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014